中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

19 records (took 0.035 seconds)

    Novel SIK Inhibitors
    17.
    发明公开
    Novel SIK Inhibitors 审中-公开

    公开(公告)号：US20240124450A1

    公开(公告)日：2024-04-18

    申请号：US18466034

    申请日：2023-09-13

    Applicant: Pfizer Inc.

    Inventor： Andrea Nicole Bootsma ,  David Christopher Ebner ,  Daniel Wei-Shung Kung ,  Matthew Alexander Perry ,  Daniel Copley Schmitt ,  Joseph Walter Strohbach ,  Atli Thorarensen

    IPC: C07D471/04

    CPC classification number: C07D471/04

    Abstract: A compound of formula I having the structure:




    or a pharmaceutically acceptable salt thereof, wherein A1 and A2 are independently O or S; X is selected from CH2, CD2, NR3, O, and S, where R3 is selected from hydrogen, C1-C4 linear or branched chain alkyl, halo(C1-C4)linear or branched chain alkyl, and hydroxyl(C1-C4)linear or branched chain alkyl; Y and Z are selected from C and N, where when Y is C, then Z is N, and when Y is N, then Z is C; R1 and R2 are independently selected from hydrogen, deuterium, C1-C4 linear or branched chain alkyl, etc.; or a C1-C2 alkyl substituted with a C3-C5 cycloalkyl ring; or taken together to form a C3-C6 cycloalkyl ring; or where X is CH2 or CD2, then R1 and R2 are independently selected from hydrogen, deuterium, halogen, hydroxyl, C1-C4 linear or branched chain alkyl, etc.; R4 is selected from hydrogen, deuterium, cyano, halogen, (C1-C3) alkoxy, etc.; R5 is selected from hydrogen, deuterium, halogen, C1-C3 alkoxy, amino, (C1-C4 linear or branched chain alkyl)amino, etc.; R6 is selected from hydrogen, deuterium, halogen, CO2R7 where R7 is selected from H and C1-C4 linear or branched chain alkyl, etc.; R8 is selected from hydrogen, deuterium, and C1-C3 linear or branched chain alkyl; R9 is selected from C1-C3 linear or branched chain alkyl, and a halo(C1-C3)linear or branched chain alkyl; and, n and m are independently selected from 0, 1 and 2. The invention also relates to pharmaceutical compositions thereof and therapeutic methods of use therewith.

Patent Agency Ranking